Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Apr 10, 2018 3:27pm
180 Views
Post# 27861526

RE:RE:Intl Liver Conference - new Alstrom info on Thursday

RE:RE:Intl Liver Conference - new Alstrom info on Thursday
sunshine7 wrote:
some of the most important meeting at these symposiums are not on the meeting schedule. They are side meetings and dinners between ceos and business leaders. Let's hope Wendel has a few of these lined up.


OMG if I had a dollar for every time I've heard that line... YEARS of these "back room meetings" and exactly what has come of them?? China? Russia? LOL... NOTHING!
Bullboard Posts